LFVN - Lifevantage Corp
4.8
0.280 5.833%
Share volume: 276,856
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$4.52
0.28
0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 05-02-2024 | 10-29-2024 | 10-29-2024 | 02-05-2025 | 05-06-2025 | 09-04-2025 | 11-04-2025 | 02-04-2026 | |
| Total revenue | 48.245 M | 48.931 M | 47.214 M | 67.762 M | 58.440 M | 55.114 M | 47.561 M | 48.931 M | |
| Cost of revenue | 10.172 M | 10.022 M | 9.491 M | 13.195 M | 11.113 M | 11.065 M | 9.745 M | 12.722 M | |
| Gross profit | 38.073 M | 38.909 M | 37.723 M | 54.567 M | 47.327 M | 44.049 M | 37.816 M | 36.209 M | |
| 2.20% | -3.05% | 44.65% | -13.27% | -6.93% | -14.15% | -4.25% | |||
| Operating expenses | 16.425 M | 14.020 M | 14.848 M | 18.614 M | 17.066 M | 18.679 M | 14.853 M | 15.827 M | |
| Selling general and admin | 16.425 M | 14.020 M | 14.848 M | 18.614 M | 17.066 M | 18.679 M | 14.853 M | 15.827 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 36.139 M | 35.999 M | 35.153 M | 51.139 M | 43.274 M | 41.901 M | 35.548 M | 35.722 M | |
| -0.39% | -2.35% | 45.48% | -15.38% | -3.17% | -15.16% | 0.49% | |||
| Operating income | 1.934 M | 2.910 M | 2.570 M | 3.428 M | 4.053 M | 2.148 M | 2.268 M | 487.000 K | |
| Ebit | 1.845 M | 2.634 M | 2.519 M | 2.959 M | 4.049 M | 2.285 M | 2.154 M | 453.000 K | |
| Pretax income | 1.921 M | 2.712 M | 2.578 M | 3.089 M | 4.180 M | 2.396 M | 2.241 M | 473.000 K | |
| 41.18% | -4.94% | 19.82% | 35.32% | -42.68% | -6.47% | -78.89% | |||
| Income tax | 262.000 K | 1.407 M | 752.000 K | 539.000 K | 710.000 K | 437.000 K | 86.000 K | 197.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 1.659 M | 1.305 M | 1.826 M | 2.550 M | 3.470 M | 1.959 M | 2.155 M | 276.000 K | |
| -21.34% | 39.92% | 39.65% | 36.08% | -43.54% | 10.01% | -87.19% |